US Broker Ratings

Guardant Health, Inc. (GH) Stock Analysis: Cutting-edge Diagnostics with a 7% Upside Potential

Guardant Health, Inc. (NASDAQ: GH) has emerged as a significant player in the precision oncology space, offering a suite of cutting-edge diagnostic tests that are reshaping..

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 36.83% Upside in the Thriving Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED) is making waves in the healthcare sector with its innovative solutions for musculoskeletal disorders. With a market capitalization of $10.91 billion,..

Natera, Inc. (NTRA) Stock Analysis: Evaluating a 22.62% Potential Upside in the Diagnostics Arena

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, is gaining attention from the investor community thanks..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 26.85% Potential Upside in Health Information Services

For investors keen on opportunities within the healthcare sector, Doximity, Inc. (NYSE: DOCS) presents a compelling case. Headquartered in San Francisco, Doximity operates a thriving digital..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a 14.25% Upside Potential in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) stands out in the biotechnology landscape not only for its robust market presence but also for its potential upside of 14.25%. As..

Charles River Laboratories (CRL) Stock Analysis: Exploring Its 13.20% Potential Upside for Investors

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Exploring a 17.35% Potential Upside

Mettler-Toledo International, Inc. (NYSE: MTD), a titan in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors seeking exposure to precision..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with Robust Growth Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands tall in the healthcare sector, carving a niche in the specialty and generic drug manufacturing industry. As a leader in..

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking a Potential 114% Upside

ADMA Biologics Inc. (NASDAQ: ADMA) is emerging as a compelling opportunity within the healthcare sector, specifically in the biotechnology industry. With a market capitalization of $1.9..

RadNet, Inc. (RDNT) Stock Analysis: A 58% Potential Upside Amidst Strong Buy Ratings

In the ever-evolving world of healthcare, RadNet, Inc. (NASDAQ: RDNT) stands out as a formidable player in the diagnostics and research industry. With a market cap..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a Potential 37.68% Upside and Analyst Consensus

Option Care Health, Inc. (NASDAQ: OPCH) operates at the intersection of healthcare innovation and patient-focused services, specializing in home and alternate site infusion therapies. With its..

Teva Pharmaceutical Industries (TEVA): Investor Outlook Reveals 18% Potential Upside Amid Strong Buy Ratings

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the healthcare sector, has captured investor attention with its robust position in the drug manufacturing industry, particularly..

Corcept Therapeutics (CORT) Stock Analysis: Unraveling Its 6.14% Upside Potential

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology sector, is capturing the attention of investors with its innovative approach in addressing severe endocrinologic, oncologic,..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a Potential 57% Upside Opportunity

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, is gaining the spotlight among investors due to its focus on developing therapies for..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 55% Upside Potential Beckons Investors

Investors with an eye on the biotechnology sector may want to consider Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a company at the forefront of innovative therapeutics based..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Promising Revenue Growth and Analyst Confidence

TG Therapeutics, Inc. (NASDAQ: TGTX) has positioned itself as a formidable entity within the biotechnology sector, especially given its focus on innovative treatments for B-cell mediated..

Sanofi (SNY) Stock Analysis: Exploring a Strong Dividend Yield and 26% Potential Upside

Sanofi (SNY), a global leader in the healthcare sector, primarily operates in the pharmaceutical industry, focusing on drug manufacturing. With its headquarters in Paris, France, Sanofi’s..

Encompass Health Corporation (EHC) Stock Analysis: Uncovering a 38% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Encompass Health Corporation (NYSE: EHC) presents a compelling case with its robust growth trajectory and promising analyst ratings...

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Uncovering a 14.47% Upside Potential in the Healthcare Sector

For investors eyeing opportunities within the healthcare sector, Smith & Nephew SNATS, Inc. (NYSE: SNN) presents an intriguing option. With a rich history dating back to..

Nuvalent, Inc. (NUVL) Stock Analysis: Assessing the 3.96% Potential Upside Amidst Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company specializing in groundbreaking cancer therapies, stands at the forefront of the biotechnology industry. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds